Liaoning Chengda Biotechnology (688739.SH) is planning to become a state without a controlling shareholder. It will resume trading on February 13th.

Liaoning Chengda Biotechnology (688739.SH) announced that its controlling shareholder, Liaoning Cheng Da Co., Ltd. ("Liaoning Cheng Da"), held its 10th Board of Directors' 33rd (special) meeting on February 12, 2025, to deliberate and pass resolutions related to the election of a new board of directors. After the completion of this board transition, Shaoguan City Gaoteng Enterprise Management Co., Ltd. ("Shaoguan Gaoteng") will nominate and have more directors elected to the board than the number of independent directors on Liaoning Cheng Da's board, thereby exerting a significant impact on the company's operations and management. The controlling shareholder of Liaoning Cheng Da will change from Liaoning State-owned Assets Management Co., Ltd. ("Liaoning State-owned Assets Management") to Shaoguan Gaoteng, and the actual controller will change from Liaoning State-owned Assets Supervision and Administration Commission to no actual controller. The actual controller of the company is expected to change from Liaoning Provincial People's Government State-owned Assets Supervision and Administration Commission to no actual controller. Upon the company's application to the Shanghai Stock Exchange, the company's stock will resume trading on February 13, 2025 (Thursday).